Citizens Maintains Market Outperform on Progyny, Raises Price Target to $38
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
Citizens analyst Constantine Davides maintains Progyny (NASDAQ:PGNY) with a Market Outperform and raises the price target from $33 to $38.
Citizens analyst Constantine Davides maintains Progyny (NASDAQ:PGNY) with a Market Outperform and raises the price target from $33 to $38.